Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non Operating Income: 2020-2024

Historic Non Operating Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to $16.2 million.

  • Arcutis Biotherapeutics' Non Operating Income fell 51.34% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 40.60%. This contributed to the annual value of $16.2 million for FY2024, which is 37.22% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Non Operating Income stood at $16.2 million for FY2024, which was up 37.22% from $11.8 million recorded in FY2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Non Operating Income peaked at $16.2 million during FY2024, and registered a low of $173,000 during FY2021.
  • For the 3-year period, Arcutis Biotherapeutics' Non Operating Income averaged around $11.3 million, with its median value being $11.8 million (2023).
  • In the last 5 years, Arcutis Biotherapeutics' Non Operating Income tumbled by 82.11% in 2021 and then surged by 3,264.74% in 2022.
  • Over the past 5 years, Arcutis Biotherapeutics' Non Operating Income (Yearly) stood at $967,000 in 2020, then slumped by 82.11% to $173,000 in 2021, then surged by 3,264.74% to $5.8 million in 2022, then surged by 102.47% to $11.8 million in 2023, then skyrocketed by 37.22% to $16.2 million in 2024.